The use of prognosis scoring systems to time donor stem cell transplantation may extend the lives of patients treated for myelodysplastic syndromes, according to a study in the American Journal of Hematology. Researchers in Italy found that delayed transplantation may be better for patients whose early illness is considered very low- or low-risk by the World Health Organization classification-based Prognostic Scoring System and low-risk by the International Prognostic Scoring System.

Full Story:

Related Summaries